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 xv 
Abstract 
Individual proteins have a specific three-dimensional structure that gives them their 
unique function. However, a protein must be folded from a linear string of amino acids 
in order to gain this native conformation and thus function. There are many hurdles to a 
protein attaining and maintaining its native conformation. Stresses that are encountered 
in the life of a protein, such as changes in pH, temperature and oxidative stress, can 
promote protein misfolding or unfolding. In addition, some genetic mutations can 
modify a protein such that a non-native conformation is more energetically favourable 
than the native state. The unfolding or misfolding of a protein makes it more likely that 
it will aggregate with itself. There are more than 40 human diseases associated with the 
inappropriate deposition of aggregated protein. It is well known that there is a well-
defined and efficient quality control system to deal with intracellular proteins that have 
either unfolded or are misfolded. Cells have a range of molecular chaperones to inhibit 
inappropriate aggregation and if this fails the cell labels the proteins with ubiquitin for 
degradation via the proteasome. However, many proteins are secreted from cells into 
the extracellular environment and there are many protein deposition disorders 
associated with extracellular protein deposits, outside the reach of the well-characterised 
intracellular quality control system.  
 
This thesis reports that the secreted proteins haptoglobin and a2-macroglobulin have 
small heat shock protein-like chaperone activity. Both haptoglobin and a2-
macroglobulin specifically inhibited the precipitation of a variety of proteins induced by 
either heat or oxidation, including proteins in unfractionated human serum. In addition, 
it was demonstrated that haptoglobin and a2-macroglobulin inhibit the precipitation of 
stressed proteins by forming solubilized complexes with them, cannot protect enzymes 
from heat-induced loss of function, and lack ATPase activity and the ability to 
independently refold proteins following stresses. In addition, data presented here shows 
that clusterin, haptoglobin and a2-macroglobulin exert potent effects on amyloid 
formation, and provide evidence to suggest that these effects are exerted via interactions 
with pre-fibrillar species. These findings suggest that clusterin, haptoglobin and a2-
macroglobulin are an important element in the control of extracellular protein 
misfolding. 
